Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate

Journal of Medical Microbiology

Volumn 62, Issue PART3, 2013, Pages 421-428

  Leejae, Sukanlaya ^a   Hasap, Laila ^a   Voravuthikunchai, Supayang Piyawan ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CAROTENOID; PHLOROGLUCINOL DERIVATIVE; PIGMENT; RHODOMYRTONE; SINGLET OXYGEN; STAPHYLOXANTHIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOSYNTHESIS; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; DRUG INHIBITION; DRUG ISOLATION; EX VIVO STUDY; IN VITRO STUDY; INCUBATION TEMPERATURE; INNATE IMMUNITY; MACROMOLECULE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; ANTIOXIDANTS; BLOOD; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MOLECULAR STRUCTURE; MYRTACEAE; PIGMENTS, BIOLOGICAL; PLANT LEAVES; STAPHYLOCOCCUS AUREUS; XANTHONES; XANTHOPHYLLS;

EID: 84874209409     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.047316-0     Document Type: Article

References (53)

1. Al Refaii, A. & Alix, J. H. (2009). Ribosome biogenesis is temperaturedependent and delayed in Escherichia coli lacking the chaperones DnaK or DnaJ. Mol Microbiol 71, 748-762.
2. Artini, M., Scoarughi, G. L., Papa, R., Cellini, A., Carpentieri, A., Pucci, P., Amoresano, A., Gazzola, S., Cocconcelli, P. S. & Selan, L. (2011). A new anti-infective strategy to reduce adhesion-mediated virulence in Staphylococcus aureus affecting surface proteins. Int J Immunopathol Pharmacol 24, 661-672.
3. B regulon. J Bacteriol 186, 4085-4099.
4. Clauditz, A., Resch, A., Wieland, K. P., Peschel, A. & Götz, F. (2006). Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect Immun 74, 4950-4953.
5. Dachriyanus, S., Sargent, M. V., Skelton, B. W., Soediro, I., Sutisna, M., White, A. H. & Yulinah, E. (2002). Rhodomyrtone, an antibiotic from Rhodomyrtus tomentosa. Aust J Chem 55, 229-232.
6. Daum, R. S. (2008). Removing the golden coat of Staphylococcus aureus. N Engl J Med 359, 85-87.
7. Dhand, A. & Sakoulas, G. (2012). Reduced vancomycin susceptibility among clinical Staphylococcus aureus isolates ('the MIC Creep'): implications for therapy. F1000 Med Rep 4, 4.
8. El-Agamey, A., Lowe, G. M., McGarvey, D. J., Mortensen, A., Phillip, D. M., Truscott, T. G. & Young, A. J. (2004). Carotenoid radical chemistry and antioxidant/pro-oxidant properties. Arch Biochem Biophys 430, 37-48.
9. Escaich, S. (2008). Antivirulence as a new antibacterial approach for chemotherapy. Curr Opin Chem Biol 12, 400-408.
10. B activity depends on RsbU in Staphylococcus aureus. J Bacteriol 183, 1843-1852.
11. Haebich, D. & Von Nussbaum, F. (2008). "Superbugs bunny" outsmarts our immune defense. ChemMedChem 3, 1173-1177.
12. Hammond, R. K. & White, D. C. (1970a). Inhibition of carotenoid hydroxylation in Staphylococcus aureus by mixed-function oxidase inhibitors. J Bacteriol 103, 607-610.
13. Hammond, R. K. & White, D. C. (1970b). Inhibition of vitamin K2 and carotenoid synthesis in Staphylococcus aureus by diphenylamine. J Bacteriol 103, 611-615.
14. Hiranrat, A. & Mahabusarakam, W. (2008). New acylphloroglucinols from the leaves of Rhodomyrtus tomentosa. Tetrahedron 64, 11193-11197.
15. Hu, B., Mayer, M. P. & Tomita, M. (2006). Modeling Hsp70-mediated protein folding. Biophys J 91, 496-507.
16. Hung, D. T., Shakhnovich, E. A., Pierson, E. & Mekalanos, J. J. (2005). Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization. Science 310, 670-674.
17. Kahlon, A. K., Roy, S. & Sharma, A. (2010). Molecular docking studies to map the binding site of squalene synthase inhibitors on dehydrosqualene synthase of Staphylococcus aureus. J Biomol Struct Dyn 28, 201-210.
18. Karamatsu, M. L., Thorp, A. W. & Brown, L. (2012). Changes in community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections presenting to the pediatric emergency department: comparing 2003 to 2008. Pediatr Emerg Care 28, 131-135.
19. B in Staphylococcus aureus reveals its function as a global regulator of virulence genes. J Bacteriol 180, 4814-4820.
20. Kuroda, M., Nagasaki, S. & Ohta, T. (2007). Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to β-lactams in methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 59, 425-432.
21. Kurt, N., Rajagopalan, S. & Cavagnero, S. (2006). Effect of Hsp70 chaperone on the folding and misfolding of polypeptides modeling an elongating protein chain. J Mol Biol 355, 809-820.
22. Lang, S., Livesley, M. A., Lambert, P. A., Littler, W. A. & Elliott, T. S. (2000). Identification of a novel antigen from Staphylococcus epidermidis. FEMS Immunol Med Microbiol 29, 213-220.
23. Lennette, E. H., Balows, A., Hausler, W. J. J. & Shadomy, H. J. (eds) (1985). Manual of Clinical Microbiology, 4th edn. Washington, DC: American Society for Microbiology.
24. Limsuwan, S. & Voravuthikunchai, S. P. (2008). Boesenbergia pandurata (Roxb.) Schltr., Eleutherine americana Merr. and Rhodomyrtus tomentosa (Aiton) Hassk. as antibiofilm producing and antiquorum sensing in Streptococcus pyogenes. FEMS Immunol Med Microbiol 53, 429-436.
25. Limsuwan, S., Subhadhirasakul, S. & Voravuthikunchai, S. P. (2009a). Medicinal plants with significant activity against important pathogenic bacteria. Pharm Biol 47, 683-689.
26. Limsuwan, S., Trip, E. N., Kouwen, T. R., Piersma, S., Hiranrat, A., Mahabusarakam, W., Voravuthikunchai, S. P., Van Dijl, J. M. & Kayser, O. (2009b). Rhodomyrtone: a new candidate as natural antibacterial drug from Rhodomyrtus tomentosa. Phytomedicine 16, 645-651.
27. Liu, G. Y. & Nizet, V. (2009). Color me bad: microbial pigments as virulence factors. Trends Microbiol 17, 406-413.
28. Liu, G. Y., Essex, A., Buchanan, J. T., Datta, V., Hoffman, H. M., Bastian, J. F., Fierer, J. & Nizet, V. (2005). Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J Exp Med 202, 209-215.
29. Liu, C.-I., Liu, G. Y., Song, Y., Yin, F., Hensler, M. E., Jeng, W.-Y., Nizet, V., Wang, A. H.-J. & Oldfield, E. (2008). A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence. Science 319, 1391-1394.
30. Mishra, N. N., Liu, G. Y., Yeaman, M. R., Nast, C. C., Proctor, R. A., McKinnell, J. & Bayer, A. S. (2011). Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides. Antimicrob Agents Chemother 55, 526-531.
31. Mitchell, G., Lafrance, M., Boulanger, S., Séguin, D. L., Guay, I., Gattuso, M., Marsault, E., Bouarab, K. & Malouin, F. (2012). Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. J Antimicrob Chemother 67, 559-568.
32. Mohamed, G. A. & Ibrahim, S. R. M. (2007). Eucalyptone G, a new phloroglucinol derivative and other constituents from Eucalyptus globulus Labill. ARKIVOC 15, 281-291.
33. Nuño, G., Zampini, I. C., Ordoñez, R. M., Alberto, M. R., Arias, M. E. & Isla, M. I. (2012). Antioxidant/antibacterial activities of a topical phytopharmaceutical formulation containing a standardized extract of Baccharis incarum, an extremophile plant species from Argentine Puna. Phytother Res 26, 1759-1767.
34. Oh, K.-B., Nam, K.-W., Ahn, H., Shin, J., Kim, S. & Mar, W. (2010). Therapeutic effect of (Z)-3-(2,5-dimethoxyphenyl)-2-(4-methoxyphenyl) acrylonitrile (DMMA) against Staphylococcus aureus infection in a murine model. Biochem Biophys Res Commun 396, 440-444.
35. Okesola, A. O. (2011). Community-acquired methicillin-resistant Staphylococcus aureus-a review of literature. Afr J Med Med Sci 40, 97-107.
36. Pacheco, R. L., Lobo, R. D., Oliveira, M. S., Farina, E. F., Santos, C. R., Costa, S. F., Padoveze, M. C., Garcia, C. P., Trindade, P. A. & other authors (2011). Methicillin-resistant Staphylococcus aureus (MRSA) carriage in a dermatology unit. Clinics (Sao Paulo) 66, 2071-2077.
37. Pandit, J., Danley, D. E., Schulte, G. K., Mazzalupo, S., Pauly, T. A., Hayward, C. M., Hamanaka, E. S., Thompson, J. F. & Harwood, H. J. J., Jr (2000). Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis. J Biol Chem 275, 30610-30617.
38. Pelz, A., Wieland, K. P., Putzbach, K., Hentschel, P., Albert, K. & Götz, F. (2005). Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J Biol Chem 280, 32493-32498.
39. 30 carotenoid pathway of Staphylococcus aureus. J Bacteriol 181, 6184-6187.
40. René, O. & Alix, J. H. (2011). Late steps of ribosome assembly in E. coli are sensitive to a severe heat stress but are assisted by the HSP70 chaperone machine. Nucleic Acids Res 39, 1855-1867.
41. Saising, J., Hiranrat, A., Mahabusarakam, W., Ongsakul, M. & Voravuthikunchai, S. P. (2008). Rhodomyrtone from Rhodomyrtus tomentosa (Aiton) Hassk. as a natural antibiotic for staphylococcal cutaneous infections. J Health Sci 54, 589-595.
42. Saising, J., Ongsakul, M. & Voravuthikunchai, S. P. (2011). Rhodomyrtus tomentosa (Aiton) Hassk. ethanol extract and rhodomyrtone: a potential strategy for the treatment of biofilm-forming staphylococci. J Med Microbiol 60, 1793-1800.
43. Sianglum, W., Srimanote, P., Wonglumsom, W., Kittiniyom, K. & Voravuthikunchai, S. P. (2011). Proteome analyses of cellular proteins in methicillin-resistant Staphylococcus aureus treated with rhodomyrtone, a novel antibiotic candidate. PLoS ONE 6, e16628.
44. Sianglum, W., Srimanote, P., Taylor, P. W., Rosado, H. & Voravuthikunchai, S. P. (2012). Transcriptome analysis of responses to rhodomyrtone in methicillin-resistant Staphylococcus aureus. PLoS ONE 7, e45744.
45. Singh, V. K., Utaida, S., Jackson, L. S., Jayaswal, R. K., Wilkinson, B. J. & Chamberlain, N. R. (2007). Role for dnaK locus in tolerance of multiple stresses in Staphylococcus aureus. Microbiology 153, 3162-3173.
46. Song, Y., Lin, F.-Y., Yin, F., Hensler, M., Rodrígues Poveda, C. A., Mukkamala, D., Cao, R., Wang, H., Morita, C. T. & other authors (2009a). Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus. J Med Chem 52, 976-988.
47. Song, Y., Liu, C.-I., Lin, F.-Y., No, J. H., Hensler, M., Liu, Y.-L., Jeng, W.-Y., Low, J., Liu, G. Y. & other authors (2009b). Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results. J Med Chem 52, 3869-3880.
48. Stefani, S., Chung, D. R., Lindsay, J. A., Friedrich, A. W., Kearns, A. M., Westh, H. & Mackenzie, F. M. (2012). Meticillin-resistant Staphylococcus aureus (MRSA): global epidemiology and harmonisation of typing methods. Int J Antimicrob Agents 39, 273-282.
49. Visutthi, M., Srimanote, P. & Voravuthikunchai, S. P. (2011). Responses in the expression of extracellular proteins in methicillinresistant Staphylococcus aureus treated with rhodomyrtone. J Microbiol 49, 956-964.
50. Voravuthikunchai, S. P., Dolah, S. & Charernjiratrakul, W. (2010). Control of Bacillus cereus in foods by Rhodomyrtus tomentosa (Ait.) Hassk. leaf extract and its purified compound. J Food Prot 73, 1907-1912.
51. Walsh, C. T. & Fischbach, M. A. (2008). Inhibitors of sterol biosynthesis as Staphylococcus aureus antibiotics. Angew Chem Int Ed Engl 47, 5700-5702.
52. Wang, R., Braughton, K. R., Kretschmer, D., Bach, T. H., Queck, S. Y., Li, M., Kennedy, A. D., Dorward, D. W., Klebanoff, S. J. & other authors (2007). Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 13, 1510-1514.
53. Wieland, B., Feil, C., Gloria-Maercker, E., Thumm, G., Lechner, M., Bravo, J. M., Poralla, K. & Götz, F. (1994). Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus. J Bacteriol 176, 7719-7726.